FIELD: medicine.
SUBSTANCE: present invention refers to biotechnology and medicine. There are presented versions (aCt1 and aCt2) of one-domain antibodies specifically binding the Chlamydia trachomatis antigen. There are described versions of the method of inhibiting an infection caused by Chlamydia wherein the method involves the preparation of elementary bodies C.trachomatis by a therapeutically effective amount of the nanoantibody aCt1 or aCt2 before being attached to infected target cells.
EFFECT: use of the invention provides the antibodies to detect and block the infections Chlamydia trachomatis that can find application in medicine.
6 cl, 4 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MOLECULAR TYPING CHLAMYDIA TRACHOMATIS | 2008 |
|
RU2378364C1 |
RECOMBINANT PSEUDO-ADENOVIRAL PARTICLE STRAIN EXPRESSING THE CHLAMYDIA TRACHOMATIS CHIMERIC GENE MBL-CT666, A METHOD FOR PREPARING IT, AN IMMUNOGENIC COMPOSITION FOR PROTECTION AGAINST HUMAN UROGENITAL CHLAMYDIOSIS | 2019 |
|
RU2721123C1 |
IMMUNOGENE COMPOSITION ON BASIS OF ANTIGEN Chlamydia trachomatis (VERSIONS) AND ITS USE | 2004 |
|
RU2352356C2 |
METHOD FOR CHLAMYDIA TRACHOMATIS GENOTYPING | 2010 |
|
RU2443782C1 |
METHOD OF TREATMENT OF COMPLICATED UROGENITAL CLAMIDIOSIS | 2007 |
|
RU2361595C1 |
CHLAMYDIAL VACCINE AND METHOD FOR ITS PREPARATION | 2016 |
|
RU2676768C2 |
STRAIN OF HYBRID CULTURED ANIMAL CELLS OF MUS MUSCULUS L USED FOR PRODUCTION OF MONOCLONAL ANTIBODIES TO CHLAMYDIA | 1998 |
|
RU2158760C2 |
NANOANTIBODIES aMh1, aMh2 BINDING ANTIGEN OF MYCOPLASMA HOMINTS, METHOD OF PRODUCING THEM, METHOD OF TREATING MYCOPLASMA HOMINIS INFECTION | 2011 |
|
RU2484095C1 |
NANOANTIBODY SPECIFICALLY BINDING CEA PROTEIN, METHOD OF ITS USAGE FOR DETECTION OF THIS PROTEIN | 2012 |
|
RU2493166C1 |
SINGLE-DOMAIN ANTIBODY aMts1 SPECIFICALLY BINDING PROTEIN S100A4/Mts1, METHOD FOR PREPARING AND USING FOR DETECTION OF THIS PROTEIN | 2012 |
|
RU2484096C1 |
Authors
Dates
2013-07-20—Published
2012-01-20—Filed